Lipid structures and hormonal control Flashcards

1
Q

Risk factors for CAD (epidemiology)

A
age - major
male
cigarettes
DM
cholesterol
BP
family history of premature CAD
inflammatory biomarkers
overweight, obesity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Pathophysiology evidence for CAD

A

Vulnerable human atherosclerotic plaque
LDL-C, hypertension, diabetes and smoking lead to endothelial cell dysfunction
- v/c
- increased pltaelet and leukocyte adhesion
- smooth muscel cell migration and growth
-increased lipid deposition with reduced clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Genetic risk factors for CAD

A

any that increase LDL-C/TAG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Clinical trial evidence for CAD

A

greater reduction in LDL-C = lowered risk
more effective to treat LDL-C than HTN
secondary prevention more effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Lipid lengths

A
short: 2-5
Medium: 6-12
Long: 12-18
Very long: >18
each have a unique acyl-CoA dehydrogenase (but overlaps)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Essential lipids

A

linoleic
alpha-linoleic
arachidonic acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Trans fats

A

arise form partially hydrogenated plant oils, rancid plant oils and ruminant animal fats
effects on lipid: increase LDL, lower HDL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Ether glycerolipid structure

A

Glycerol
C1 - FA (ETHER linkage)
C2 - FA (as above)
C3 - phosphate head group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Glycerophospholipid structure

A

Glycerol + 2 FA side chains (ester linkage) + P-head group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Phosphatidylcholine (lecithin)

A

R1 = long chain, saturated
R2 = long chain, unsaturated
Marker of fetal lung maturity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lecithin: sphingomyelin ratio

A

L:S >2 mature - neonatal RDS less likely

immature <1.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Phosphatidylethanolamine (cephalin)

A

usually R1 = stearic acid
R2 = long-chain unsatuated
structural membrane phospholipids, esp in CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Phosphatidylserine

A

membrane structural phospholipid

synthesized by headgroup exchange PE + Serine –> PS + ethanolamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Phosphatidylinositol

A

R1: stearic acid
R2: arachidonic acid
low concentrations in membranes
mediator of intracellular signals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Phosphatidylglycerol

A

major component of mitochondrial membranes

component of pulmonary surfactant - can also be used as a marker for fetal lung maturity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Diphosphatidylglycerol

A

aka DPG, cardiolipins
Component of pulmonary surfactant
recognized by antiphospholipid antibody

17
Q

Sphingolipids structure

A

all are based on ceramide (with phosphocholine or sugar attached), formed from sphingosine

classes:
phosphosphingolipids
glycosphingolipids

18
Q

Sphingolipid function

A

intracellular communication
antigenic determinants of ABO blood groups
receptors for certain viruses and bacteria

19
Q

Sphingolipids - disease

A

metabolic diseases from defects in sphingolipid metabolism - often due to loss of enzymes for modifying sugars:
Tay Sachs
Fabry’s
etc.

20
Q

Fabry’s disease

A

X-linked recessive, due to loss of alpha-galactosidase A
Lysosomal accumulation of upstream glycosphingolipid
Endothelial swelling and proliferation, disturbances in intraluminal P and angiectasia –> dilated, elongated, distorted vessels –> subject to occlusion
chronic HTN, renal and heart failure
can get stroke

21
Q

Fabry’s disease diagnosis

A
family history of early stroke in males
pain in distal extremities
multiple angiokeratomas (speedo distribution)
recurrent headaches
HTN
Corneal opacities
22
Q

Fabry’s disease tx

A

prevent HTN sequelae
decrease possibility of strokes
enzyme replacement therapy

23
Q

Hormones that increase lipolysis

A
counter regulatory hormones:
epinephrine
glucagon
cortisol
GH
24
Q

Hormones that decrease lipolysis

A

Insulin: induces phosphorylation and activation of the phosphodiesterase type 3B –> decrease in cAMP –> decrease PKA

25
Q

Epinephrine - effect on lipolysis

A

immediate increase in lipolysis

cAMP dependent activation of PKA –> phosphorylation and activation of hormone-sensitive lipase

26
Q

GH - effect on lipolysis

A

overall activates HSL

lipolysis also potentiated via increase sensitivity to catecholamines

27
Q

Infection - risk factor for CAD

A

C. pneumoniae infection =associated with poor serum lipod profile
Infection with parasites/acute bacterial infection also associated with poor lipid profile

28
Q

Air pollution - CAD

A

ultra-fine particles in air combined with LDL –> accelerate narrowing and blockage of blood vessels
Air pollution + LDL work together to activate the genes that promote cellular inflammation

29
Q

CPT deficiency

A

required for transport of FAs >12
recurrent attacks of myoglobinuria and rhabdomyolysis
muscle pain, stiffness, and tenderness triggered by exercise and fasting
severe - fatal in infancy

30
Q

Very long-chain fatty acid metabolism

A

Peroxisomal first

then mitochondrial

31
Q

Acyl carnitine profiling

A

for MCAD deficiency
C8/C10 ratio
newborn screening

32
Q

X-linked ALD

A

 in the cerebral form of X-ALD, early development is normal
 first neurological manifestation commonly between ages 4 and 8.
 impaired auditory discrimination, visual disturbances, signs of dementia, spatial disorientation, poor coordination, seizures – due to CNS demyelination
 vegetative state within 2 years and then death
 patients are frequently hypocortisolemic – for some this is the only manifestation!
 some idiopathic Addison’s disease is actually due to ALD!